20 days ago
When you lose a lot of weight some folks say ”well done” but others are nervous. ls it is a sign that you are sick. I started the year at c17 stone, I ended August at 13 stone 4 pounds and it was deliberate. No booze, no biscuits: in fact my diet had become almost entirely rabbit food and fish. In an attempt to tackle cholesterol I was taking my coffee black and cheese, hitherto a great love, was out.
49 days ago
As you may be aware my type 2 diabetes was raging and I was in a bad way at around Christmas. Since then, there has been a complete lifestyle change. I cannot reverse some of the damage done but it is in my power to stop things getting worse. This morning there is a very positive an update on my weight and my blood sugars.
168 days ago
I was first up and my encounter was scheduled, it was my diabetes check up. When the Shipmans test your blood they obtain a three month average trailing score of blood sugars. So this chat was about bloods taken on March 4: two months of sobriety, healthy eating and exercise and one month of drinking and over indulgence during the olive harvest and then Christmas. Yet my results were stunning, a 25% reduction in blood sugars, albeit from a terrible start. The nurse was full of praise and said how much thinner I was looking. I think she meant I looked less fat but the trend is my friend.
2833 days ago
I did okay in 2016. The notable win being quitting smoking although that was not something I started until February 15. So I guess I don't need to start my 2017 resolutions right away. that is jolly useful as we still have a bit of Christmas cake and an excellent cheddar cheese from Uncle Chris to finish off. That brings me to resolution one.
3666 days ago
OptiBiotix Health (OPTI), the former Ducat Ventures, has announced it is contracting Netherlands-based Nizo Food Research BV to undertake pre-clinical claims support for three cholesterol-lowering ‘Lactobacillus’ strains that OptiBiotix has developed.
The company added it has contracted Nizo to assess each strain's manufacturability, gastrointestinal robustness and activity against bile salts, to determine the best strain(s) to enter human studies, whilst this should also reduce the cost, timescale, and development risk for future products. With more than 60 years’ experience, Nizo has the largest food-grade pilot plant in Europe and the work is expected to be completed by the end of this year, to facilitate the commencement of human studies early next year.
The announcement saw shares in OptiBiotix up to 9.25p-10p, but they have now slipped back to a current 8.25p-9p, capitalising the company at just under £7 million.